A Study to Evaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster Vaccines

NCT05323461 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

1800

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19
SARS-CoV-2 Infection

Interventions

BIOLOGICAL: SCTV01C
BIOLOGICAL: SCTV01E
BIOLOGICAL: Sinopharm inactivated COVID-19 vaccine
BIOLOGICAL: Comirnaty

Sponsor

Sinocelltech Ltd.